{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:39:56Z","timestamp":1792870796194,"version":"4.5.0"},"reference-count":144,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["23-75-10111"],"award-info":[{"award-number":["23-75-10111"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Mitochondria serve as an essential component in the maintenance of cardiac function, and targeting them may represent a promising approach to handling heart failure (HF). HF in this review refers to various etiologies, including ischemic cardiomyopathy, dilated cardiomyopathy, and hypertrophic cardiomyopathy, unless otherwise specified. Mitochondrial dysfunction, a distinctive feature of HF, leads to a progressive decrease in bioenergetic reserves due to switching of energy production from oxidation of fatty acids in mitochondria to glycolytic pathways. The main problem in developing methods to improve mitochondrial function lies in the fact that protein preparations injected through the bloodstream cannot enter cells through the plasma membrane. Modern gene therapy involving the delivery of missing genes to cells using adeno-associated virus (AAV) vectors has the potential to improve the function of cardiomyocytes (CMCs). This type of therapy aims to target proteins that have been lost, damaged, or altered due to pathological conditions in the myocardium. This review summarizes pathophysiological mechanisms associated with mitochondrial dysfunction, which is mainly caused by increased oxidative stress and impaired mitochondrial biodynamics under HF progression. It also addresses possible ways to modulate these processes using gene therapy. Special attention is paid to modern characteristics of AAVs that can be used as vectors for the efficient delivery of desired genes to CMCs.<\/jats:p>","DOI":"10.3390\/biomedicines14020344","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:49:44Z","timestamp":1770036584000},"page":"344","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gene Therapy for Heart Failure: Impact on Mitochondrial Dysfunction"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7838-0486","authenticated-orcid":false,"given":"Mikhail","family":"Blagonravov","sequence":"first","affiliation":[{"name":"Institute of Medicine, RUDN University, 6 Miklukho-Maklaya St, 117198 Moscow, Russia"},{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Sklifasovskaya","sequence":"additional","affiliation":[{"name":"Institute of Medicine, RUDN University, 6 Miklukho-Maklaya St, 117198 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7233-1704","authenticated-orcid":false,"given":"Ruslan","family":"Karpov","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ovechkina","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"},{"name":"Institute of Translational Medicine, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9058-2917","authenticated-orcid":false,"given":"Sofya","family":"Andrianova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"},{"name":"Joint Department with RAS Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 105066 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Syatkin","sequence":"additional","affiliation":[{"name":"Institute of Medicine, RUDN University, 6 Miklukho-Maklaya St, 117198 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6637-8098","authenticated-orcid":false,"given":"Vsevolod","family":"Belousov","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"},{"name":"Institute of Translational Medicine, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia"},{"name":"Life Improvement by Future Technologies (LIFT) Center, 143025 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-9926","authenticated-orcid":false,"given":"Andrey","family":"Mozhaev","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia"},{"name":"Institute of Translational Medicine, Pirogov Russian National Research Medical University, 117997 Moscow, Russia"},{"name":"Joint Department with RAS Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Faculty of Biology and Biotechnology, National Research University Higher School of Economics, 105066 Moscow, Russia"},{"name":"Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, 117513 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.molmed.2014.01.005","article-title":"Mitochondrial pathology: Stress signals from the energy factory","volume":"20","author":"Raimundo","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1172\/JCI120849","article-title":"Mitochondrial dysfunction in pathophysiology of heart failure","volume":"128","author":"Zhou","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-023-01009-x","article-title":"Mitophagy for cardioprotection","volume":"118","author":"Titus","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Gallo, G., Rubattu, S., and Volpe, M. (2024). Mitochondrial dysfunction in heart failure: From pathophysiological mechanisms to therapeutic opportunities. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25052667"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1080\/15548627.2021.2022289","article-title":"Perinatal versus adult loss of ULK1 and ULK2 distinctly influences cardiac autophagy and function","volume":"18","author":"Harris","year":"2022","journal-title":"Autophagy"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/cvr\/cvx017","article-title":"Metabolism in cardiomyopathy: Every substrate matters","volume":"113","author":"Ritterhoff","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","article-title":"Mitochondrial structure and function in human heart failure","volume":"135","author":"Hinton","year":"2024","journal-title":"Circ. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, M., Lv, J., Pan, Z., Wang, D., Zhao, L., and Guo, X. (2022). Mitochondrial dysfunction in heart failure and its therapeutic implications. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.945142"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Elorza, A.A., and Soffia, J.P. (2021). mtDNA Heteroplasmy at the Core of Aging-Associated Heart Failure. An integrative view of OXPHOS and mitochondrial life cycle in cardiac mitochondrial physiology. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.625020"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1161\/CIRCULATIONAHA.120.046001","article-title":"Mitochondrial DNA copy number and incident heart failure: The atherosclerosis risk in communities (ARIC) study","volume":"141","author":"Hong","year":"2020","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mongelli, A., Mengozzi, A., Geiger, M., Gorica, E., Mohammed, S.A., Paneni, F., Ruschitzka, F., and Costantino, S. (2023). Mitochondrial epigenetics in aging and cardiovascular diseases. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1204483"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_14","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10741-012-9340-0","article-title":"Mitochondrial dysfunction in heart failure","volume":"18","author":"Rosca","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102993","DOI":"10.1016\/j.jbc.2023.102993","article-title":"RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagy","volume":"299","author":"Soh","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.freeradbiomed.2023.09.015","article-title":"Asiatic acid protects against pressure overload-induced heart failure in mice by inhibiting mitochondria-dependent apoptosis","volume":"208","author":"Du","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/2047487319870344","article-title":"Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies","volume":"27","author":"Aimo","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106038","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kub\u00e1nek, M., Schimerov\u00e1, T., Piherov\u00e1, L., Brodehl, A., Krebsov\u00e1, A., Ratnavadivel, S., Stanasiuk, C., Hans\u00edkov\u00e1, H., Zeman, J., and Pale\u010dek, T. (2020). Desminopathy: Novel desmin variants, a new cardiac phenotype, and further evidence for secondary mitochondrial dysfunction. J. Clin. Med., 9.","DOI":"10.3390\/jcm9040937"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.15252\/emmm.201404669","article-title":"Cardiac LXR\u03b1 protects against pathological cardiac hypertrophy and dysfunction by enhancing glucose uptake and utilization","volume":"7","author":"Cannon","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","article-title":"Cardiac metabolism in heart failure: Implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","article-title":"Expert consensus document: Mitochondrial function as a therapeutic target in heart failure","volume":"14","author":"Brown","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gao, C., and Hou, L. (2023). Branched chain amino acids metabolism in heart failure. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1279066"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Meeran, M.F.N., Azimullah, S., Al Ahbabi, M.M., Jha, N.K., Lakshmanan, V.K., Goyal, S.N., and Ojha, S. (2020). Nootkatone, a dietary fragrant bioactive compound, attenuates dyslipidemia and intramyocardial lipid accumulation and favorably alters lipid metabolism in a rat model of myocardial injury: An in vivo and in vitro study. Molecules, 25.","DOI":"10.3390\/molecules25235656"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/s41401-023-01107-5","article-title":"Cardiomyocyte peroxisome proliferator-activated receptor \u03b1 prevents septic cardiomyopathy via improving mitochondrial function","volume":"44","author":"Zhu","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jacbts.2019.02.003","article-title":"Malonyl CoA decarboxylase inhibition improves cardiac function post-myocardial infarction","volume":"4","author":"Wang","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.18632\/aging.101881","article-title":"Sex differences in the aging human heart: Decreased sirtuins, pro-inflammatory shift and reduced anti-oxidative defense","volume":"11","author":"Pozdniakova","year":"2019","journal-title":"Aging"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.2174\/1381612821666150710150445","article-title":"Myocardial energy substrate metabolism in heart failure: From pathways to therapeutic targets","volume":"21","author":"Fukushima","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD+ redox balance as a therapy for heart failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cmet.2018.01.016","article-title":"The mitochondrial acylome emerges: Proteomics, regulation by sirtuins, and metabolic and disease implications","volume":"27","author":"Carrico","year":"2018","journal-title":"Cell Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"114931","DOI":"10.1016\/j.biopha.2023.114931","article-title":"Cellular and molecular biology of sirtuins in cardiovascular disease","volume":"164","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-021-03510-6","article-title":"Distinct fission signatures predict mitochondrial degradation or biogenesis","volume":"593","author":"Kleele","year":"2021","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-021-03214-x","article-title":"Function and regulation of the divisome for mitochondrial fission","volume":"590","author":"Kraus","year":"2021","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Tokuyama, T., and Yanagi, S. (2023). Role of mitochondrial dynamics in heart diseases. Genes, 14.","DOI":"10.3390\/genes14101876"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00395-022-00966-z","article-title":"Beta-3 adrenergic receptor overexpression reverses aortic stenosis-induced heart failure and restores balanced mitochondrial dynamics","volume":"117","author":"Prados","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.biocel.2009.05.004","article-title":"Dynamic organization of mitochondria in human heart and in myocardial disease","volume":"41","author":"Hoppel","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Eldarov, C.M., Vangely, I.M., Vays, V.B., Sheval, E.V., Holtze, S., Hildebrandt, T.B., Kolosova, N.G., Popkov, V.A., Plotnikov, E.Y., and Zorov, D.B. (2020). Mitochondria in the nuclei of rat myocardial cells. Cells, 9.","DOI":"10.3390\/cells9030712"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Kuznetsov, A.V., Javadov, S., Margreiter, R., Hagenbuchner, J., and Ausserlechner, M.J. (2022). Analysis of mitochondrial function, structure, and intracellular organization in situ in cardiomyocytes and skeletal muscles. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042252"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Li, A., Gao, M., Jiang, W., Qin, Y., and Gong, G. (2020). Mitochondrial dynamics in adult cardiomyocytes and heart diseases. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.584800"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ding, Q., Qi, Y., and Tsang, S.Y. (2021). Mitochondrial biogenesis, mitochondrial dynamics, and mitophagy in the maturation of cardiomyocytes. Cells, 10.","DOI":"10.3390\/cells10092463"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhang, T., Li, Z., Xu, Y., Xu, C., Wang, H., and Rui, T. (2025). Regulation of mitochondrial dynamics in cardiomyocytes: Implications for cardiac health and disease. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1652683"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41401-020-00518-y","article-title":"Drp1-dependent mitochondrial fission in cardiovascular disease","volume":"42","author":"Jin","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCRESAHA.123.322512","article-title":"Distinct roles of DRP1 in conventional and alternative mitophagy in obesity cardiomyopathy","volume":"133","author":"Tong","year":"2023","journal-title":"Circ. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"25907","DOI":"10.1074\/jbc.M115.665695","article-title":"Resistance of dynamin-related protein 1 oligomers to disassembly impairs mitophagy, resulting in myocardial inflammation and heart failure","volume":"290","author":"Cahill","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Thai, P.N., Seidlmayer, L.K., Miller, C., Ferrero, M., Dorn, G.W., Schaefer, S., Bers, D.M., and Dedkova, E.N. (2019). Mitochondrial quality control in aging and heart failure: Influence of ketone bodies and mitofusin-stabilizing peptides. Front. Physiol., 10.","DOI":"10.3389\/fphys.2019.00382"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e005131","DOI":"10.1161\/CIRCHEARTFAILURE.118.005131","article-title":"Mitochondrial morphology, dynamics, and function in human pressure overload or ischemic heart disease with preserved or reduced ejection fraction","volume":"12","author":"Chaanine","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e017835","DOI":"10.1161\/JAHA.120.017835","article-title":"Transcriptomic and functional analyses of mitochondrial dysfunction in pressure overload-induced right ventricular failure","volume":"10","author":"Hwang","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_54","first-page":"e471","article-title":"Gene therapy in cardiovascular disease: Recent advances and future directions in science: A science advisory from the American Heart Association","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Chaanine, A.H., LeJemtel, T.H., and Delafontaine, P. (2020). Mitochondrial pathobiology and metabolic remodeling in progression to overt systolic heart failure. J. Clin. Med., 9.","DOI":"10.3390\/jcm9113582"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2015.04.056","article-title":"Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease","volume":"763","author":"Ong","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chen, L., Liu, B., Qin, Y., Li, A., Gao, M., Liu, H., and Gong, G. (2021). Mitochondrial fusion protein Mfn2 and its role in heart failure. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.681237"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Chen, L., Qin, Y., Liu, B., Gao, M., Li, A., Li, X., and Gong, G. (2022). PGC-1\u03b1-mediated mitochondrial quality control: Molecular mechanisms and implications for heart failure. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.871357"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20517\/jca.2022.42","article-title":"The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure","volume":"3","author":"Werbner","year":"2023","journal-title":"J. Cardiovasc. Aging"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Fonseka, O., Gare, S.R., Chen, X., Zhang, J., Alatawi, N.H., Ross, C., and Liu, W. (2025). Molecular mechanisms underlying heart failure and their therapeutic potential. Cells, 14.","DOI":"10.3390\/cells14050324"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gao, S., Li, D., Wang, B., Zhang, H., and Chen, L. (2025). Two promising approaches in the treatment of myocardial infarction: Stem cells and gene therapy. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1540066"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"101345","DOI":"10.1016\/j.jacbts.2025.101345","article-title":"Precision medicine: Therapeutically targeting mitochondrial alterations in heart failure","volume":"10","author":"Parker","year":"2025","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1038\/s41467-022-31544-5","article-title":"Sex differences in heart mitochondria regulate diastolic dysfunction","volume":"13","author":"Cao","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/cvr\/cvab188","article-title":"PGC-1\u03b1 deficiency reveals sex-specific links between cardiac energy metabolism and EC-coupling during development of heart failure in mice","volume":"118","author":"Naumenko","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ymthe.2004.06.110","article-title":"Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors","volume":"10","author":"Du","year":"2004","journal-title":"Mol. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: In vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"101532","DOI":"10.1016\/j.omtm.2025.101532","article-title":"AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administration","volume":"33","author":"Wang","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1385\/MB:28:1:21","article-title":"Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes","volume":"28","author":"Djurovic","year":"2004","journal-title":"Mol. Biotechnol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhang, H., Zhan, Q., Huang, B., Wang, Y., and Wang, X. (2022). AAV-mediated gene therapy: Advancing cardiovascular disease treatment. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.952755"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","article-title":"Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: Analysis of recurrent cardiovascular events and mortality","volume":"114","author":"Zsebo","year":"2014","journal-title":"Circ. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): A randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00395-025-01123-y","article-title":"AAV-mediated overexpression of CPT1B protects from cardiac hypertrophy and heart failure in a murine pressure overload model","volume":"120","author":"Ruf","year":"2025","journal-title":"Basic Res. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41420-025-02524-7","article-title":"Gene therapy prevents onset of mitochondrial cardiomyopathy in neonatal mice with Ndufs6 deficiency","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"92ra64","DOI":"10.1126\/scitranslmed.3002097","article-title":"Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model","volume":"3","author":"Pleger","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jacc.2011.03.054","article-title":"S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes","volume":"58","author":"Brinks","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-024-05223-6","article-title":"CAV3 alleviates diabetic cardiomyopathy via inhibiting NDUFA10-mediated mitochondrial dysfunction","volume":"22","author":"Guo","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"AAV-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu. Rev. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1073\/pnas.79.6.2077","article-title":"Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells","volume":"79","author":"Samulski","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0378-1119(83)90217-2","article-title":"Cloning of infectious adeno-associated virus genomes in bacterial plasmids","volume":"23","author":"Laughlin","year":"1983","journal-title":"Gene"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.118.311587","article-title":"Human cardiac gene therapy","volume":"123","author":"Ishikawa","year":"2018","journal-title":"Circ. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1128\/JVI.00161-16","article-title":"Characterization of the adeno-associated virus 1 and 6 sialic acid binding site","volume":"90","author":"Huang","year":"2016","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/JVI.77.4.2768-2774.2003","article-title":"Characterization of tissue tropism determinants of adeno-associated virus type 1","volume":"77","author":"Hauck","year":"2003","journal-title":"J. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jgm.896","article-title":"Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector","volume":"8","author":"Lu","year":"2006","journal-title":"J. Gene Med."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Issa, S.S., Shaimardanova, A.A., Solovyeva, V.V., and Rizvanov, A.A. (2023). Various AAV serotypes and their applications in gene therapy: An overview. Cells, 12.","DOI":"10.3390\/cells12050785"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jgm.1129","article-title":"AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid","volume":"10","author":"Su","year":"2008","journal-title":"J. Gene Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/hum.2005.16.235","article-title":"Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors","volume":"16","author":"Chen","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","article-title":"Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: Vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1128\/JVI.01288-06","article-title":"Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1752-8062.2010.00190.x","article-title":"Comparative cardiac gene delivery of adeno-associated virus serotypes 1-9 reveals that AAV6 mediates the most efficient transduction in mouse heart","volume":"3","author":"Zincarelli","year":"2010","journal-title":"Clin. Transl. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1089\/hum.2011.035","article-title":"Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines","volume":"22","author":"Bish","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/gt.2010.168","article-title":"Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo","volume":"18","author":"White","year":"2011","journal-title":"Gene Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1128\/JVI.07232-11","article-title":"Structural insight into the unique properties of adeno-associated virus serotype 9","volume":"86","author":"DiMattia","year":"2012","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of Adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing \u03b11-antitrypsin: Interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/mt.2011.157","article-title":"Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders","volume":"19","author":"Bevan","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1538-7836.2006.02220.x","article-title":"Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy","volume":"5","author":"Vandendriessche","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: Implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","article-title":"Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle","volume":"74","author":"Chirmule","year":"2000","journal-title":"J. Virol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/brv.12718","article-title":"Humoral immune responses to AAV gene therapy in the ocular compartment","volume":"96","author":"Whitehead","year":"2021","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000369273","article-title":"Unique roles of TLR9- and MyD88-dependent and -independent pathways in adaptive immune responses to AAV-mediated gene transfer","volume":"7","author":"Rogers","year":"2015","journal-title":"J. Innate Immun."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/14728222.2010.501333","article-title":"Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses","volume":"14","author":"Huang","year":"2010","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","article-title":"Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV capsid-specific CD8+ T cells","volume":"129","author":"Rogers","year":"2017","journal-title":"Blood"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ymthe.2019.11.011","article-title":"Type I IFN sensing by cDCs and CD4+ T cell help are both requisite for cross-priming of AAV capsid-specific CD8+ T cells","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI36891","article-title":"Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors","volume":"119","author":"Pien","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/hum.1998.9.4-477","article-title":"Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors","volume":"9","author":"Manning","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.ymthe.2024.07.016","article-title":"A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders","volume":"32","author":"Vrellaku","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.copbio.2019.01.002","article-title":"Engineering the AAV capsid to evade immune responses","volume":"60","author":"Barnes","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1038\/s41598-021-88614-9","article-title":"Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies","volume":"11","author":"Ito","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"103601","DOI":"10.1016\/j.jpet.2025.103601","article-title":"Investigation of dose-exposure-response relationship for adeno-associated virus-mediated delivery of antibody genes","volume":"392","author":"Rajwade","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.omtm.2021.10.010","article-title":"Modulating immune responses to AAV by expanded polyclonal T-regs and capsid specific chimeric antigen receptor T-regulatory cells","volume":"23","author":"Arjomandnejad","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/hum.2023.227","article-title":"Role of FoxP3+ regulatory T cells in modulating immune responses to adeno-associated virus gene therapy","volume":"35","author":"Biswas","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/mt.2011.22","article-title":"Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer","volume":"19","author":"Pulicherla","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: A randomized double-blind placebo-controlled study: The Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/humc.2017.070","article-title":"Use of adeno-associated virus vector for cardiac gene delivery in large-animal surgical models of heart failure","volume":"28","author":"Katz","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.0000153338.47507.83","article-title":"Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer","volume":"111","author":"Kikuchi","year":"2005","journal-title":"Circulation"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCRESAHA.118.313811","article-title":"Atrial-specific gene delivery using an adeno-associated viral vector","volume":"124","author":"Ni","year":"2019","journal-title":"Circ. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-1-4939-6588-5_20","article-title":"Molecular cardiac surgery with recirculating delivery (MCARD): Procedure and vector transfer","volume":"1521","author":"Katz","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.athoracsur.2013.04.021","article-title":"Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure","volume":"96","author":"Fargnoli","year":"2013","journal-title":"Ann. Thorac. Surg."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/HCO.0000000000000386","article-title":"Cardiac gene therapy with adeno-associated virus-based vectors","volume":"32","author":"Chamberlain","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","article-title":"Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure","volume":"51","author":"Kawase","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1038\/mt.2014.127","article-title":"Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure","volume":"22","author":"Ishikawa","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCHEARTFAILURE.112.971325","article-title":"AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling","volume":"6","author":"Fish","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J. Card. Fail."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/gt.2013.63","article-title":"Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model","volume":"21","author":"Weber","year":"2014","journal-title":"Gene Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jacc.2004.05.074","article-title":"Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: Comparison with surgical and percutaneous intramyocardial gene delivery","volume":"44","author":"Raake","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.gt.3303035","article-title":"Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors","volume":"15","author":"Raake","year":"2008","journal-title":"Gene Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/hum.2013.044","article-title":"Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8","volume":"24","author":"Pan","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Katz, M.G., Fargnoli, A.S., Williams, R.D., Steuerwald, N.M., Isidro, A., Ivanina, A.V., Sokolova, I.M., and Bridges, C.R. (2014). Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca2+ adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg., 148, 1065\u20131073.e2; discussion1072\u20133.","DOI":"10.1016\/j.jtcvs.2014.05.070"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/gt.2015.109","article-title":"Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure","volume":"23","author":"Greenberg","year":"2016","journal-title":"Gene Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/eurheartj\/ehw019","article-title":"Gene therapy for the treatment of heart failure: Promise postponed","volume":"37","author":"Hulot","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.05.004","article-title":"Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts","volume":"158","author":"Ritterhoff","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.122.063759","article-title":"Extracellular vesicle-encapsulated adeno-associated viruses for therapeutic gene delivery to the heart","volume":"148","author":"Li","year":"2023","journal-title":"Circulation"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/2\/344\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:18:50Z","timestamp":1770182330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/2\/344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":144,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biomedicines14020344"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14020344","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}